Article
Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP/p97-LC3-mHTT complex.
Acta pharmacologica Sinica - 1 Oct 2021
Li Xiao-Jing, Zhang Yuan-Yuan, Fu Yu-Hua, Zhang Hao, Li He-Xuan, Li Quan-Fu, Li Hai-Ling, Tan Ren-Ke, Jiang Chen-Xiao, Jiang Wei, Li Zeng-Xia, Luo Cheng, Lu Bo-Xun, Dang Yong-Jun
Abstract excerpt
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by toxic aggregates of mutant huntingtin protein (mHTT) in the brain. Decreasing mHTT is a potential strategy for therapeutic purpose of HD. Valosin-containing protein (VCP/p97) is a crucial regulator of proteostasis, which regulates the degradation of damaged protein through proteasome and autophagy pathway. Since VCP has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
